Skip to main content

Table 5 Transiently induced genes

From: Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment

Symbol Fold Change Description
ABCA1 1.8 ATP-binding cassette, sub-family A (ABC1), member 1
ABCC3 1.7 ATP-binding cassette, sub-family C (CFTR/MRP), member 3
AIM2 1.6 Related to IFI16
ARRB1 1.7 arrestin, beta 1
C1QA 1.6 complement component 1, q subcomponent, A chain
C1QB 2.0 complement component 1, q subcomponent, B chain
CALML4 1.8 calmodulin-like 4
CDKN1C 2.2 cyclin-dependent kinase inhibitor 1C (p57, Kip2)
CMKLR1 2.0 chemokine-like receptor 1, chimerin
CTSL1 2.4 cathepsin L1 (lysosomal cysteine proteinase)
CUTL1 1.5 cut-like 1, CCAAT displacement protein (Drosophila)
CXCL10 4.0 chemokine (C-X-C motif) ligand 10
FAM46A 1.6 family with sequence similarity 46, member A
FFAR2 (GPR43) 2.7 free fatty acid receptor 2.
hCG_1776259 1.9 hypothetical protein FLJ23556 (unknown function)
IL1RN 2.1 interleukin 1 receptor antagonist
JAK2 1.7 Janus kinase 2 (a protein tyrosine kinase)
LILRA3 1.6 leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3
MARCKS 2.4 myristoylated alanine-rich protein kinase C substrate
RHOB 1.7 ras homolog gene family, member B
RRAS 1.9 related RAS viral (r-ras) oncogene homolog
SAMD4A 2.6 sterile alpha motif domain containing 4A
SLC31A2 1.7 solute carrier family 31 (copper transporters), member 2
TCN2 2.2 transcobalamin II; macrocytic anemia
TLR1 1.6 toll-like receptor 1
TNFAIP6 (TSG-6) 2.1 tumor necrosis factor, alpha-induced protein 6
TNFSF10 (TRAIL) 2.3 tumor necrosis factor (ligand) superfamily, member 10
TRAFD1 (FLN29) 2.0 TRAF-type zinc finger domain containing 1
VDR 1.6 vitamin D (1,25- dihydroxyvitamin D3) receptor
  1. Genes are significantly induced at day 3 but either not induced at any other time point, or day 3 fold change is at least 20% higher than other days.